Treatment of Premature Retinopathy with Biosimilar Ranibizumab Seems Effective.

Published Date: 27 Apr 2023

Treatment of Retinopathy of Prematurity with Biosimilar Ranibizumab Seems Effective.

Read Full News

Latest News

Satralizumab Shows Promise for Thyroid Eye Disease

An antibody targeting the interleukin-6 receptor may help reduce bulging of the eyes and inflammation in patients with thyroid eye disease, early phase 3 data show.

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Mechanisms That Matter: Understanding Intravitreal Therapies for Retinal Vascular Diseases

Mechanisms That Matter: Understanding Intravitreal Therapies for Retinal Vascular Diseases

Eye Specialists Flag Concerns About Pricey Lenses in Cataract Surgery

Multifocal lenses are not for everyone, experts say

Anti-VEGF Agent Collects Big Win in Trial of Diabetic Retinopathy

More than 60% of tarcocimab-treated patients had reduced severity

New Agents for AMD Preserve Vision, Dramatically Reduce Treatment Burden

Bispecific antibody fares well against faricimab, two gene therapies extend treatment intervals

Todays Updates

Osimertinib's OS Benefit in Resected NSCLC Persists 8 Years

Even years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.

Pelvic RT Tied to Longer Survival in Cervical Cancer

In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.

New Data Put ADCs on the Map in Relapsed SCLC

Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.

Real-World Liso-Cel Results in MCL Consistent With Trials

Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.

Antibiotic Use in Hospice Linked to Higher Mortality Risk

Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.

Todays Updates

Osimertinib's OS Benefit in Resected NSCLC Persists 8 Years

Even years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.

Pelvic RT Tied to Longer Survival in Cervical Cancer

In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.

New Data Put ADCs on the Map in Relapsed SCLC

Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.

Real-World Liso-Cel Results in MCL Consistent With Trials

Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.

Antibiotic Use in Hospice Linked to Higher Mortality Risk

Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.

Latest News

An antibody targeting the interleukin-6 receptor may help reduce bulging of the eyes and inflammation in patients with thyroid eye disease, early phase 3 data show.

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Mechanisms That Matter: Understanding Intravitreal Therapies for Retinal Vascular Diseases

Multifocal lenses are not for everyone, experts say

More than 60% of tarcocimab-treated patients had reduced severity

Bispecific antibody fares well against faricimab, two gene therapies extend treatment intervals

News All Time

EyePoint's Drug for Age-related Eye Disease Fails Late-stage Trial, Shares Tank

EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision ⁠from causes unrelated to the targeted disease, sending its...

Massage Matches Clinic Probing for Infant Tear Duct Blockage

Gently massaging the tear sacs of infants with blocked tear ducts may be as effective as clinic-based probing for clearing tearing and discharge, a noninferiority trial finds.

Can Dexamethasone Drops Prevent Retinal Disease in Preemies?

Dexamethasone eye drops administered in premature infants with early-stage retinal disease appear to reduce the odds of progression to treatment-requiring disease.

Urinary Drug Tadalafil Linked to Glaucoma Risk

Men taking tadalafil for lower urinary tract symptoms face a 22% higher risk of developing glaucoma than those who do not take the drug, a new study finds.

Study Links Uveitis to Higher Risk for Psychiatric Illness

Noninfectious uveitis is linked to higher rates of psychiatric comorbidities, with Black patients most affected, a new study finds.

Nonvalved Drainage Device Benefits Kids With Glaucoma

In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.

What Is Causing Progressive Vision Problems in a 32-Year-Old Woman?

A glaucoma diagnosis at a young age should prompt timely genetic testing

Woman Develops Chorioretinal Anastomosis at Site of Photocoagulation Scar

A serendipitous iatrogenic effect following laser surgery in a patient with NF1

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

GLP-1 Drug Linked to Cases of Rare Vision-Altering Condition

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism

What Caused Visual Disturbance in Kidney Transplant Patient?

Genetic testing identified PAX2 gene variant

Floaters Affect Vision of Kidney Transplant Patient

UL97- and UL54-resistant CMV retinitis treated with multivirus-specific T-cell therapy

Massage Gun Eye Injury: Retinal Tears, Detachment

'Hesitant historian' did not initially disclose that he used the product on his eyes

AI Smart Glasses Show Promise, Limitations as Aid for Patients With Low Vision

Good accuracy for recognizing common objects, mixed results by object size, colors, text, money

Recommended News For You

Cognitive Bias Modification App Fosters Alcohol Avoidance

A study on lung cancer provides additional proof of the value of screening.

CDC Alerts on Dramatic Rise in Human Parvovirus B19

Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments

Vaccine shows promise for pancreatic cancer, study finds

Pain’s Toll: Frailty Risk for Childhood Cancer Survivors

Distribution of fat could influence cancer risk, study suggests

Recommended Articles For You

Hematopoietic Aging Load and Disease Susceptibility: Mechanisms, Clinical Implications, and Management 

Evidence-Based Advances in Hematology for Specialists 

Screening for Occult Platelet Dysfunction: Mechanisms, Clinical Implications, and Evidence-Based Approaches 

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

2.

Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer

3.

FDA Panel Endorses Capivasertib Use in Prostate Cancer

4.

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

5.

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

1.

Progressive Changes in Tumor Tissue Fluid Transport and Interstitial Pressure: Mechanisms, Clinical Implications, and Therapeutic Advances

2.

Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025

3.

Colon cancer: Risk factors, warning signs and treatment options 

4.

Targeting Oncology: Expanding Combinatorial Strategies by 2025

5.

Integrated Techniques in Oncology in the Digital Era

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

2.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV

4.

How Platelet Disorders Can Affect the Body

5.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot